Proceedings of the National Academy of Sciences, Volume 123, Issue 13, March 2026. SignificanceSubcutaneous injection is increasingly favored over intravenous infusion for antibody therapies such as IgG for multiple reasons including faster administration and greater convenience for patients. Subcutaneous delivery commonly requires ...
PNAS published a clinical update in Research Highlights on 24 Mar 2026.
The item focuses on Fab–Fc and Fab–Fab interactions of variable strength and valency contribute to the high concentration viscosity of IgG1 antibodies.
Review the original article for the full source wording and details.